& Quality Control
We are the only supplier of SARMs with third-party purity validation from analytical chemists credentialed by the National Certification Commission in Chemistry and Chemical Engineering (NCCCCE).
Recent high-impact research published in the Journal of the American Medical Association shows that most of the SARM products currently available online are either incorrectly labelled or low in purity (https://www.ncbi.nlm.nih.gov/pubmed/29183075).
In contrast, Umbrella Labs has implemented strict QA/QC protocols to ensure maximum purity of all our products. We employ industry-leading High Performance Liquid Chromatography and Liquid/Gas Chromatography-Mass Spectrometry in our manufacturing pipeline, and routine analyses are conducted in a CLIA environment using a flexible range of Thermo Scientific and Agilent modalities:
Unfortunately for research scientists in academia and R&D, most manufacturers of SARMs and peptides—including many large, multinational chemical companies—limit their analyses to HPLC-UV in order to save time and money on quality control. Take a look at their Certificates of Analysis and see for yourself…
At Umbrella Labs, we do not take shortcuts.
By harnessing new-generation mass spectrometry analysis, we can augment our purity assessments by enhancing sensitivity and adding a new dimension of measurement. Without question, our LC/MS-MS approach offers better quality assurance and control than conventional HPLC-UV alone. This is especially crucial for analysis of SARMs, many of which exist as diastereomeric mixtures. Quantitative resolution of these mixtures demands highly sensitive instrumentation, such as our triple-quadrupole spectrometer.
Purity assessment with LC/MS involves:
Method development, data acquisition/processing and report generation are performed using fully-licensed, comprehensive chromatography system software in order to comply with regulatory data integrity requirements.